The adventures of a blossoming psychonaut

Police say the attacker was likely overdosing on a new potent form of LSD. “What’s happening is whenever we see that a person has taken all of his clothes off and has become violent, it’s indicative of this excited delirium that’s caused by overdose of drugs,” said Armando Aguilar of the Miami Fraternal Order of Police. “What’s happening is inside their body their organs are burning up alive.”

…

Subtitle D—Synthetic Drugs

SEC. 1151. SHORT TITLE.

This subtitle may be cited as the ‘Synthetic Drug Abuse Prevention Act of 2012’.

SEC. 1152. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.

(a) Cannabimimetic Agents- Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:

‘(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

‘(2) In paragraph (1):

‘(A) The term ‘cannabimimetic agents’ means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:

‘(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.

‘(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.

‘(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.

‘(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.

‘(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.

‘(B) Such term includes—

‘(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);

‘(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);

‘(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM67;

‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);

‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);

‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);

‘(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

‘(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);

‘(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);

‘(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-39;

‘(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

‘(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

‘(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);

‘(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-; and

‘(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).’.

(b) Other Drugs- Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:

‘(1 4-methylmethcathinone (Mephedrone).

‘(19) 3,4-methylenedioxypyrovalerone (MDPV).

‘(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

‘(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

‘(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

‘(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

‘(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).

‘(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).

‘(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

‘(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

‘(2 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).’.

SEC. 1153. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.

Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended—

(1) by striking ‘one year’ and inserting ‘2 years’; and

(2) by striking ‘six months’ and inserting ‘1 year’.

SEC. 1154. PROHIBITION ON IMPOSING MANDATORY MINIMUM SENTENCES.

Section 401(b)(1)(C) of the Controlled Substances Act (21 U.S.C. 841(b)(1)(C)) is amended by adding at the end the following: ‘Any mandatory minimum term of imprisonment required to be imposed under this subparagraph shall not apply with respect to any controlled substance added to schedule I by the Synthetic Drug Abuse Prevention Act of 2012.’.

Passed the Senate May 24, 2012.

Attest:

Secretary.

112th CONGRESS

2d Session

S. 3187

AN ACT

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.